New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide …MarketWatch (press release)The study title is "An Open Label Non-Randomized Pilot Study To Evaluate the Safety of the GeNO NITROSYL Delivery System in Patients Being Eva…
New Data Shows GeNO LLC Nitric Oxide Delivery System Provided Nitric Oxide With Low Levels of Nitrogen Dioxide for …
COCOA, Fla., April 19, 2012 /PRNewswire/ — New data presented today studied the safety of the GeNO system for delivering inhaled nitric oxide (NO) to patients being evaluated for cardiac transplant. …
Bloomington Teen Takes Action for Organ Donation – CIproud.com
Bloomington Teen Takes Action for Organ DonationCIproud.comShe even partnered with Secretary of State Jesse White last year to promote organ donation. "He decided I was going to be the spokesperson. So he just called my mom one day and asked, '…
Coroner's verdict in Corsham brain death inquest – This Is Wiltshire
Coroner's verdict in Corsham brain death inquestThis Is WiltshireA mother has said hearing chances to treat her daughter's killer brain condition were missed by doctors and contributed to her death was "like having your worst nightmares re…
Gift of Life Network using peer pressure to boost organ donation – Guelph Mercury
Canada NewsWireGift of Life Network using peer pressure to boost organ donationGuelph MercuryThat's the latest strategy Ontario's Trillium Gift of Life Network is using to boost sagging rates of organ donor registration across the province. Sta…
Beyond R-CHOP-21: What's New in Diffuse Large B-Cell Lymphoma – OncLive
OncLiveBeyond R-CHOP-21: What's New in Diffuse Large B-Cell LymphomaOncLiveThe current standard for patients with advanced diffuse large B-cell lymphoma (DLBCL) is R-CHOP-21 (21-day rituximab-cyclophosphamidedoxorubicin- vincristine-prednisone). Ho…
Inform Genomics completes first phase in oral mucositis risk prediction study – News-Medical.net
Inform Genomics completes first phase in oral mucositis risk prediction studyNews-Medical.netWhen commercialized, this product will be available for the hematology oncology stem cell transplant market and will complement the target market of our lead p…
NEW DATA RELEASED AT ISHLT MEETING MAY IMPACT TREATMENT FOR PATIENTS WITH … – CisionWire (press release)
NEW DATA RELEASED AT ISHLT MEETING MAY IMPACT TREATMENT FOR PATIENTS WITH …CisionWire (press release)While there is no known cure for PAH, treatment options include medications, oxygen therapy, and depending on severity of the disease, lung transplan…
New Data Released At ISHLT Meeting May Impact Treatment for Patients With … – MarketWatch (press release)
New Data Released At ISHLT Meeting May Impact Treatment for Patients With …MarketWatch (press release)While there is no known cure for PAH, treatment options include medications, oxygen therapy, and depending on severity of the disease, lung transpla…
XDx Announces Positive Results from European CARGO II Study of AlloMap … – PharmiWeb.com (press release)
XDx Announces Positive Results from European CARGO II Study of AlloMap …PharmiWeb.com (press release)AlloMap is XDx's FDA-cleared and CE-marked, easy and convenient, non-invasive blood test that aids physicians in determining a stable heart trans…